Naijing Hu
- Topics
- RNA Research and Splicing (5 papers)SARS-CoV-2 and COVID-19 Research (3 papers)RNA modifications and cancer (3 papers)
- Partner nations
- ChinaCzechiaSouth Korea
In The Last Decade
Naijing Hu
13 papers receiving 441 citations
Peers
Comparison fields: 5 of 53
- Molecular Biology 323
- Infectious Diseases 108
- Cancer Research 92
- Oncology 46
- Immunology 44
Countries citing papers authored by Naijing Hu
This map shows the geographic impact of Naijing Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naijing Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naijing Hu more than expected).
Fields of papers citing papers by Naijing Hu
This network shows the impact of papers produced by Naijing Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naijing Hu. The network helps show where Naijing Hu may publish in the future.
Co-authorship network of co-authors of Naijing Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Naijing Hu. A scholar is included among the top collaborators of Naijing Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naijing Hu. Naijing Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 20 | |
| 7 | 9 | |
| 8 | 5 | |
| 9 | 3 | |
| 10 | 125 | |
| 11 | 5 | |
| 12 | 11 | |
| 13 | 27 | |
| 14 | 1 | |
| 15 | 39 | |
| 16 | 203 |
About Naijing Hu
Naijing Hu is a scholar working on Immunology, Infectious Diseases and Virology, having authored 16 papers that have together received 451 indexed citations. Recurring topics across this work include RNA Research and Splicing (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (92 citations), Infectious Diseases (108 citations) and Molecular Biology (323 citations). Naijing Hu has collaborated with scholars based in China, Czechia and South Korea. Frequent co-authors include Yuanchao Xue, Changchang Cao, Zhaokui Cai, Rong Ye, Xiaohua Yu, Juan Chen, Cong Xia, Sui Wang, Shunmin He and Lei Wang. Their work appears in journals such as Nature, Nature Communications and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.